Literature DB >> 17644472

Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function.

Sean Balmain1, Neal Padmanabhan, William R Ferrell, John J Morton, John J V McMurray.   

Abstract

BACKGROUND: Up to 50% of patients with the clinical syndrome of heart failure have preserved left ventricular systolic function (HF-PSF). These patients may have abnormalities of ventriculo-vascular coupling, due to increased vascular and ventricular stiffness.
METHODS: We compared arterial compliance, microvascular vasodilator function and venous capacitance (VC) in 3 groups of patients (n=12 each) matched for the presence of coronary heart disease: 1) HF and preserved systolic function (HF-PSF), 2) HF and reduced systolic function (HF-RSF) and 3) controls (no HF, PSF). Arterial compliance was assessed by measuring aortic pulse wave velocity (PWV) with applanation tonometry. Cutaneous microvascular function was assessed using Laser Doppler imaging (LDI) coupled with iontophoresis of endothelium-dependent (acetylcholine) and -independent (sodium nitroprusside) vasodilators. VC was measured using venous occlusion plethysmography.
RESULTS: PWV was significantly higher in HF-PSF subjects than in both HF-RSF and control groups (10.7 [1.1], 8.9 [1.7] and 8.6 [2.1] m/s respectively, p<0.05). Acetylcholine and nitroprusside induced vasodilatation were equally impaired in HF-PSF and HF-RSF, as compared to controls (p<0.01). VC was higher in HF-RSF subjects compared with HF-PSF subjects (1.75 [0.41], 1.34 [0.34] ml/100 ml forearm vol. respectively, p<0.05).
CONCLUSIONS: These findings are consistent with a more marked increase in vascular stiffness in HF-PSF than in HF-RSF and suggest that arterial stiffness, dynamic vasodilator function and venous abnormalities may be implicated in the complex pathophysiology of HF-PSF.

Entities:  

Mesh:

Year:  2007        PMID: 17644472     DOI: 10.1016/j.ejheart.2007.06.003

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  20 in total

1.  Relationship between pulse transit time and blood pressure is impaired in patients with chronic heart failure.

Authors:  Daniel R Wagner; Norbert Roesch; Patrick Harpes; Heinrich Körtke; Pierre Plumer; Amir Saberin; Viviane Chakoutio; Denis Oundjede; Charles Delagardelle; Jean Beissel; Georges Gilson; Ingrid Kindermann; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2010-05-16       Impact factor: 5.460

Review 2.  The genetics of congestive heart failure.

Authors:  Calum A MacRae
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

3.  Muscle metaboreflex-induced central blood volume mobilization in heart failure.

Authors:  Donal S O'Leary; Danielle Senador; Robert A Augustyniak
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-01       Impact factor: 4.733

4.  Elastic properties of peripheral arteries in heart failure patients in comparison with normal subjects.

Authors:  Chengyu Liu; Dingchang Zheng; Lina Zhao; Peng Li; Bin Li; Alan Murray; Changchun Liu
Journal:  J Physiol Sci       Date:  2013-03-22       Impact factor: 2.781

Review 5.  Decongestion in acute heart failure.

Authors:  Robert J Mentz; Keld Kjeldsen; Gian Paolo Rossi; Adriaan A Voors; John G F Cleland; Stefan D Anker; Mihai Gheorghiade; Mona Fiuzat; Patrick Rossignol; Faiez Zannad; Bertram Pitt; Christopher O'Connor; G Michael Felker
Journal:  Eur J Heart Fail       Date:  2014-03-05       Impact factor: 15.534

6.  Impact of Exercise Training on Peak Oxygen Uptake and its Determinants in Heart Failure with Preserved Ejection Fraction.

Authors:  Wesley J Tucker; Michael D Nelson; Rhys I Beaudry; Martin Halle; Satyam Sarma; Dalane W Kitzman; Andre La Gerche; Mark J Haykowksy
Journal:  Card Fail Rev       Date:  2016-11

Review 7.  Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction.

Authors:  Mark J Haykowsky; Corey R Tomczak; Jessica M Scott; D Ian Paterson; Dalane W Kitzman
Journal:  J Appl Physiol (1985)       Date:  2015-04-24

Review 8.  Developing therapies for heart failure with preserved ejection fraction: current state and future directions.

Authors:  Javed Butler; Gregg C Fonarow; Michael R Zile; Carolyn S Lam; Lothar Roessig; Erik B Schelbert; Sanjiv J Shah; Ali Ahmed; Robert O Bonow; John G F Cleland; Robert J Cody; Ovidiu Chioncel; Sean P Collins; Preston Dunnmon; Gerasimos Filippatos; Martin P Lefkowitz; Catherine N Marti; John J McMurray; Frank Misselwitz; Savina Nodari; Christopher O'Connor; Marc A Pfeffer; Burkert Pieske; Bertram Pitt; Giuseppe Rosano; Hani N Sabbah; Michele Senni; Scott D Solomon; Norman Stockbridge; John R Teerlink; Vasiliki V Georgiopoulou; Mihai Gheorghiade
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035

9.  Altered Hemodynamics and End-Organ Damage in Heart Failure: Impact on the Lung and Kidney.

Authors:  Frederik H Verbrugge; Marco Guazzi; Jeffrey M Testani; Barry A Borlaug
Journal:  Circulation       Date:  2020-09-08       Impact factor: 29.690

Review 10.  Congestion occurrence and evaluation in acute heart failure scenario: time to reconsider different pathways of volume overload.

Authors:  Alberto Palazzuoli; Isabella Evangelista; Ranuccio Nuti
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.